A gold nanoparticle/peptide vaccine designed to induce SARS-CoV-2-specific CD8 T cells: a double-blind, randomized, phase 1 study in Switzerland. - Besson J; Audran R; Karlen M; Miauton A; Hajjami HM; Warpelin-Decrausaz L; Sene L; Schaufelberger S; Faivre V; Faouzi M; Hartley MA; Spertini F; et al. (BMC infectious diseases, 2025)